PHARMACEUTICAL EXCIPIENTS MARKET ANALYSIS

Pharmaceutical Excipients Market, By Product Type (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers and Diluents, Binders, Suspension, Viscosity Agents, Coatings, Flavoring Agents, Disintegrants, Colorants, Preservatives, Others), By Formulation (Oral, Parenteral, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

In March 2024, Roquette, a prominent player in plant-based ingredients and pharmaceutical excipients, has announced an agreement to acquire IFF Pharma Solutions, a global producer of excipients for oral dosage forms. This strategic move aims to strengthen Roquette's position as a key partner in the pharmaceutical industry.
In October 2023, Clariant, a company dedicated to sustainability and specialty chemicals, introduced a new lineup of advanced pharmaceutical ingredient solutions aimed at advancing the development of safe and efficient medicines. Additionally, Clariant Health Care expanded its selection of functional excipients to address challenges related to the delivery and bioavailability of active pharmaceutical ingredients (APIs).
In September 2023, Roquette, known for its plant-based ingredients and its provision of pharmaceutical and nutraceutical excipients, added three new grades of excipients to its portfolio. These new additions are designed to cater specifically to moisture-sensitive active pharmaceutical and nutraceutical ingredients, enhancing their stability and performance.